Skip to main content
. Author manuscript; available in PMC: 2013 Apr 1.
Published in final edited form as: Am J Kidney Dis. 2012 Feb 4;59(4):513–522. doi: 10.1053/j.ajkd.2011.11.044

Figure 1. eGFR trajectories and 95% confidence intervals defined by trajectory modeling. Dotted lines denote 95% confidence intervals.

Figure 1

Trajectory Group 1 (persistently low levels of eGFR): 63% of patients with a mean probability of assignment 0.88 (±0.24)

Trajectory Group 2 (progressive loss of eGFR): 25% of patients with a mean probability of assignment 0.86 (±0.27)

Trajectory Group 3 (accelerated loss of eGFR): 9% of patients with a mean probability of assignment 0.91 (±0.25)

Trajectory Group 4 (catastrophic loss of eGFR): 3% of patients with a mean probability of assignment 0.99 (±0.11)